See if same day discharge after bariatric surgery is safe for select patients
Official title: Transition to Ambulatory Bariatric Surgery (TABS) Trial
Run by Vanderbilt University Medical Center · NCT07011628 · Data updated 2026-11-12
This trial tests whether people having sleeve gastrectomy or gastric bypass can go home the same day or should stay at least one night, to see if ER visits within a week differ.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 55 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | October 1, 2027 |
| Study ends | May 1, 2028 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT07011628 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with BMI ≤ 60 kg/m2 undergoing primary sleeve gastrectomy or gastric bypass at the sponsor site without the listed exclusion criteria.
✕Probably not a fit
Patients with significant comorbidities or risks listed in the exclusion criteria may not benefit and could be at higher risk with same day discharge.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a pragmatic, parallel, randomized, open-label study comparing same day discharge with at least one night of hospital stay after bariatric procedures (sleeve gastrectomy or gastric bypass). The primary outcome is the rate of emergency department visits within seven days post-surgery, and a secondary aim is to compare 30-day total charges between the two care pathways. Eligible participants are adults with BMI up to 60 kg/m2 undergoing primary bariatric surgery at the sponsor site, with several medical exclusions. The trial is led by Vanderbilt University Medical Center to assess safety and feasibility of same day discharge in this setting.
Why it matters
Potential benefit: If same day discharge is found to be safe and cost-effective, it could shorten hospital stays and reduce healthcare costs for bariatric patients.
How similar studies have gone: Prior studies in similar surgical pathways have shown mixed safety signals; this study adds contemporary, pragmatic data for bariatric procedures.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI ≤ 60 kg/m2 * Primary Sleeve gastrectomy or Gastric Bypass, * Undergoing bariatric surgery at sponsor site Exclusion Criteria: * Type 1 Diabetes * Myocardial Infarction * Unstable Angina or Heart Failure * Prior Stroke * Solid organ transplantation * Systemic glucocorticoid prior 28 days * Severe Obstructive Sleep Apnea * Uncontrolled Hypertension (Systolic \> 150, Diastolic \> 90) * Untreated Hyperthyroidism * Chronic Kidney Disease (EGFR \< 60) * Current anticoagulant use, * Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months \> 8.5%) * Chronic opioid use * Insulin dependence. * Need for extended venous thromboembolic event prophylaxis, * \> 1 lifetime bariatric surgery (revisional or conversion bariatric surgery) * Patient lives \> 130 miles from the hospital. * Tobacco use in last 12 months * Desire to become pregnant or active pregnancy * Prisoners * Unable or unwilling to follow-up * Unable to understand or provide consent
Where it's running
-
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Study coordinator: Jason Samuels
- Email: jason.m.samuels@vumc.org
- Phone: (615) 322 - 4504
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating the long-term health effects of obesity treatments on women
This study is trying to see how different obesity treatments affect women's health over time, including their nutrition, bones, muscles, and pregnancy outcomes.
-
Using tirzepatide before bariatric surgery to improve outcomes
This study is testing if taking tirzepatide before weight loss surgery can help patients recover better and have fewer complications after the surgery.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
-
Mother and baby health after bariatric surgery in pregnancy
This study follows pregnant women who have had bariatric surgery and those who have not to see how nutrition, pregnancy health, and baby outcomes compare.
-
Understanding glucagon and sugar metabolism after meals in people with and without PBH after weight-loss surgery
This study tests how glucagon and post-meal glucose handling differ between people who have post-bariatric surgery hypoglycemia and those who don’t.
-
Collagen Supplements After Sleeve Gastrectomy
This observational study looks to see if taking collagen-containing supplements after sleeve gastrectomy affects muscle mass, body composition, and body image in adults who had bariatric surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.